Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:
• Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.
Locations
United States
New York
Jacobs Institute
RECRUITING
Buffalo
Contact Information
Primary
Carlos Pena, PhD, MS
cpena@jacobsinstitute.org
2404810824
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 10
Treatments
Other: SHIELD Study Arm
Active treatment with the Pipeline SHIELD Device
Related Therapeutic Areas
Sponsors
Leads: Jacobs institute